| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Galectin Therapeutics Inc. (GALT) have been net sellers, shedding 98,287 shares worth roughly $496K on balance. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
On the other side, 1 insider reduced a position over the period. GALT sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 5.61M | $19.37M | - | |
| CFO | 100.0K | $345.0K | - | |
| CEO | 100.0K | $345.0K | - | |
| Dir | 60.0K | $207.0K | - | |
| Dir | 60.0K | $207.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 21, 2025 | Eldred Kary81 | Director | Buy | 1,000 | $2.93 | $2,925.00 | +1.6% | +85.8% | +40.5% | |
| Jul 17, 2025 | Freeman Kevin D57 | Director | Buy | 5,000 | $2.90 | $14,495.00 | +11.2% | +79.6% | +44.6% | |
| Dec 30, 2024 | Shlevin Harold H.89 | Director | Buy | 6,500 | $1.16 | $7,540.00 | +74.7% | +10.9% | +270.9% | |
| Dec 24, 2024 | Freeman Kevin D57 | Director | Buy | 10,000 | $0.81 | $8,134.00 | +28.8% | +96.3% | +379.4% | |
| Dec 24, 2024 | Zordani Richard A. Jr.52 | Director | Buy | 10,000 | $0.82 | $8,164.00 | +31.2% | +96.3% | +379.4% | |
| Dec 24, 2024 | Eldred Kary81 | Director | Buy | 13,469 | $0.82 | $11,044.58 | +26.8% | +96.3% | +379.4% | |
| Dec 23, 2024 | Lewis Joel59 | President And CEO | Sale+OE | 56,000 | $0.89 | $49,610.40 | -5.9% | +85.4% | +348.3% | |
| Dec 23, 2024 | Jamil Khurram | Chief Medical Officer | Sale+OE | 13,654 | $0.88 | $12,044.19 | -34.1% | +85.4% | +348.3% | |
| Dec 23, 2024 | Callicutt Jack W62 | Chief Financial Officer | Sale+OE | 40,000 | $0.89 | $35,492.00 | -84.0% | +85.4% | +348.3% | |
| Oct 23, 2024 | Eldred Kary81 | Director | Buy | 500 | $2.60 | $1,300.00 | +1.0% | -52.3% | +98.8% |